Cart
sales@molnova.com
Trierucin
CAS No. 2752-99-0
Trierucin( —— )
Catalog No. M21429 CAS No. 2752-99-0
Trierucin is a trierucic acid triglyceride from the seed oil.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 35 | Get Quote |
|
| 25MG | 72 | Get Quote |
|
| 50MG | 125 | Get Quote |
|
| 100MG | 214 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTrierucin
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrierucin is a trierucic acid triglyceride from the seed oil.
-
DescriptionTrierucin is a trierucic acid triglyceride from the seed oil.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2752-99-0
-
Formula Weight1053.75
-
Molecular FormulaC69H128O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:32.5 mg/mL (3.84 mM)
-
SMILESCCCCCCCC/C=C\CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCC/C=C\CCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mersel M et al. Intracellular lipase activities in heart and skeletal muscle homogenates. The absence of trierucin cleavage by the heart: a possible biochemical basis for erucic acid lipidosis. Biochim Biophys Acta. 1979 Feb 26;572(2):218-24.
molnova catalog
related products
-
ACT-389949
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.
-
Ibrolipim
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
-
Ganolucidic acid A
Ganolucidic acid A is a natural product that can be isolated from Ganoderma lucidum.
